Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.
Chang-Youh TsaiCheih-Yu ShenChih-Wei LiuSong-Chou HsiehHsien-Tzung LiaoKo-Jen LiCheng-Shiun LuHui-Ting LeeCheng-Sung LinCheng-Han WuYu-Min KuoChia-Li YuPublished in: Biomolecules (2020)
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interactions among genetic, epigenetic, environmental, and immunological factors. Of these contributing factors, non-coding RNAs (ncRNAs), including microRNAs (miRNAs, miRs), and long non-coding RNAs (lncRNAs) play critical roles in the post-transcriptional mRNA expression of cytokines, chemokines, and growth factors, which are essential for immune modulation. In the present review, we emphasize the roles of ncRNA expression in the immune-related cells and cell-free plasma, urine, and tissues contributing to the immunopathogenesis and tissue damage in SLE. In addition, the circular RNAs (circRNA) and their post-translational regulation of protein synthesis in SLE are also briefly described. We wish these critical reviews would be useful in the search for biomarkers/biosignatures and novel therapeutic strategies for SLE patients in the future.
Keyphrases
- systemic lupus erythematosus
- disease activity
- poor prognosis
- long non coding rna
- cell free
- induced apoptosis
- gene expression
- end stage renal disease
- oxidative stress
- immune response
- cell cycle arrest
- rheumatoid arthritis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- multiple sclerosis
- prognostic factors
- cell death
- genome wide
- peritoneal dialysis
- drug induced
- cell proliferation